COMPEL Data Show Osimertinib Plus Chemo Beats Chemo Alone for EGFRm NSCLC Following Progression Osimertinib is a targeted treatment often used as the first option for people with non-small cell lung cancer (NSCLC) that has EGFR mutations. When the cancer
Significant advancements in research, diagnosis, and treatment
Lung cancer news is constantly evolving, with significant advancements in research, diagnosis, and treatment. Here are some recent developments: Recent Breakthroughs Blood Test for Lung Cancer: The NHS has become the first health service in the world to roll out
Recognition of lung cancer
Early detection of lung cancer is key to improving outcomes. This can be achieved through improved public awareness and quick referral to specialist care when lung cancer is suspected. Symptoms of lung cancer can be vague and may be mistaken